Candriam Luxembourg S.C.A. »

Lyell Immunopharma shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2025-12-31 $235k 7.6k 30.78

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Mastercard Incorporated Cl A (MA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Gilead Sciences (GILD)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding
Millennium Management

View all funds holding Lyell Immunopharma